
Wellness & Balance LLC
Weight loss program
The drugs, taken once a week by injection, simulate naturally produced hormones that curb appetite and slow digestion, creating longer-lasting satiety. A healthy diet and exercise also assist with weight loss.
According to Healthline, written by David Mills on January 21, 2025, and fact-checked by Jill Seladi-Schulman, Ph.D.
Mounjaro and Zepbound contain the active ingredient tirzepatide. Mounjaro is approved to treat type 2 diabetes, while Zepbound has been approved for weight management treatment. “GLP-1 meds represent the first class of medications that offer effective weight-loss options for patients,” she said. “In addition, randomized clinical trials show that the GLP-1 meds are associated with significant benefits, including decreasing risk for cardiovascular disease, kidney disease, sleep apnea, and arthritis. The future is bright for GLP-1 drugs.” (https://www.healthline.com/health-news/glp-1-drugs-benefits-risks-health-outcomes)
Service Description:
-
Comprehensive Medical Evaluation
-
Reviewed detailed weight history
-
Assessed metabolic history
-
Considered lifestyle factors
-
-
Initiation of GLP-1 Therapy (Tirzepatide/Mounjaroor Zepbound
-
Medication
-
Patient education: Injection technique, storage, and rotation sites (thigh, back of arm)
-
-
Lifestyle & Behavioral Counseling
-
Developed realistic, structured exercise plan (10–15 minutes walking, strength training with alternating upper/lower body, total 25 minutes/session)
-
Encouraged a gradual increase in physical activity based on energy and fibromyalgia symptoms
-
-
Nutritional Support
-
Provided food journal and
-
Placed referral to registered dietitian for personalized meal planning
-
-
Supplementation & Adjunctive Therapies
-
Initiated Magnesium Glycinate 100 mg, increasing to 200 mg in week 2
-
Discussed the importance of hydration and balanced electrolytes during GLP-1 therapy
-
-
Monitoring and Follow-Up Plan
-
Monthly follow-ups to monitor progress, titrate medication, and review labs
-
Expected Patient Benefits:
-
Sustainable Weight Loss: GLP-1s reduce appetite
-
Metabolic Improvement: Lower insulin resistance, support glucose stabilization (prediabetes management)
-
Improved Energy: Potential secondary benefit from weight reduction and better glucose control
-
Support for Physical Activity: Structured, manageable reintroduction to movement that supports long-term fitness goals
-
Mental & Emotional Health: Renewed motivation with structured plan and clinical support;
The drugs, taken once a week by injection, simulate naturally produced hormones that curb appetite and slow digestion, creating longer-lasting satiety. A healthy diet and exercise also assist with weight loss.
According to Healthline, written by David Mills on January 21, 2025, and fact-checked by Jill Seladi-Schulman, Ph.D.
Mounjaro and Zepbound contain the active ingredient tirzepatide. Mounjaro is approved to treat type 2 diabetes, while Zepbound has been approved for weight management treatment. “GLP-1 meds represent the first class of medications that offer effective weight-loss options for patients,” she said. “In addition, randomized clinical trials show that the GLP-1 meds are associated with significant benefits, including decreasing risk for cardiovascular disease, kidney disease, sleep apnea, and arthritis. The future is bright for GLP-1 drugs.” (https://www.healthline.com/health-news/glp-1-drugs-benefits-risks-health-outcomes)




